Distinguished in Junctional Epidermolysis Bullosa

Marcel F. Jonkman

Groningen, GR, NL 
Distinguished in Junctional Epidermolysis Bullosa
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Marcel Jonkman practices in Groningen, Netherlands. Jonkman is rated as a Distinguished expert by MediFind in the treatment of Junctional Epidermolysis Bullosa. Their top areas of expertise are Epidermolysis Bullosa, Junctional Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita, and Dowling-Meara Epidermolysis Bullosa Simplex.

Their clinical research consists of co-authoring 174 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Junctional Epidermolysis Bullosa.

Locations

Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: April 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

174 Total Publications

Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa.
Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa.
Journal: The Journal of investigative dermatology
Published: December 08, 2020

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Jonkman's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile